ATTN LogoMenu

CABR Stock Surges 25% on $4 Share Offering Post Spin-Off

By ATTN Desk · Editorial oversight: Sean Han

Introduction

CARING BRANDS INC (ticker: CABR) is a wellness company focused on translating health science into over-the-counter products and intellectual property. Headquartered in Jupiter, Florida, the company develops treatments for conditions including hair loss, eczema, and vitiligo. In addition to product sales, CARING BRANDS generates revenue through licensing royalties.

Corporate Structure

As an emerging growth company and smaller reporting company under U.S. securities law, CARING BRANDS maintains scaled-back reporting requirements while trading on the Nasdaq Capital Market under the symbol CABR since November 13, 2025. Its corporate office in Jupiter supports research, development, and clinical validation of proprietary formulations. The company has a portfolio of granted and pending patents covering various products, including sunscreen and skin care.

Wellness Products

Wellness Products by deanna alys

Recent Developments and News

On September 26, 2024, Safety Shot, Inc. completed a Separation and Exchange Agreement, spinning off its wellness unit as CARING BRANDS INC. Under that agreement, Safety Shot received three million shares of CARING BRANDS stock and declared a dividend of two million shares to Safety Shot shareholders.
CARING BRANDS filed a Form 10-Q on November 14, 2025, covering its second fiscal quarter, and a Form 8-K on November 17, 2025, disclosing material events related to items 1.01, 8.01, and 9.01. On the same day as the 10-Q, the company filed a prospectus under Rule 424(b)(4) for an offering of 2,610,000 shares of common stock at $4.00 per share, including 2,110,000 shares issuable upon exercise of warrants at $3.00. The prospectus noted a prior private placement in 2024 that raised $2.11 million at $1.00 per unit.

Financial and Strategic Analysis

As of November 19, 2025, CABR closed at $0.9749, a gain of 25.18% for the session, on a volume of 590,995 shares compared to an average daily volume of 54,353. The 52-week trading range is $0.0561 to $6.00. Market capitalization stands at $19.72 million, with an enterprise value of $19.70 million. Key metrics (trailing twelve months) include:

  • Net income of -$2.0 million, a profit margin of 0.00%, return on assets of -68.51%, and return on equity of -170.46%
  • Revenue of $3,750 and levered free cash flow of $291,270
  • A balance sheet liquidity position of $73,890 in cash and a debt-to-equity ratio of 1.61%
  • Valuation multiples of Price/Sales at 4,250× and Price/Book at 6.35×

The Nasdaq listing and $4.00 per-share offering aim to enhance liquidity and support clinical development, manufacturing scale-up, and marketing efforts. The separation from Safety Shot allows management to focus solely on consumer wellness products, while warrant exercises and equity issuances will provide capital for expansion.

Market Position and Industry Context

CARING BRANDS operates in the non-prescription health and wellness segment, competing with established OTC and consumer-health companies. The company differentiates itself through patent-protected formulations for dermatological and hair-growth applications, supported by clinical research. The dual revenue model—product sales and licensing royalties—aligns with industry trends towards asset-light commercialization and extended partnerships. As regulatory scrutiny of OTC claims tightens, the emphasis on clinical backing may support market access and credibility.

tl;dr

CARING BRANDS (NASDAQ: CABR) closed at $0.9749 on November 19, 2025, following a 25.18% increase during heightened trading (590,995 shares) after its November 14 prospectus for a $4.00 per-share offering of 2.61 million shares and warrant exercises. Having spun off from Safety Shot on September 26, 2024, and listing on Nasdaq on November 13, 2025, the company plans to use proceeds for clinical trials, manufacturing scale, and product launches in its dermatology and hair-care pipeline. Future liquidity is dependent on warrant conversions and market uptake of its OTC portfolio.

Latest Stories

Loading articles...